Second antibiotic no advantage for treating super-bug Golden Staph

A world-first clinical trial has called into question the effectiveness of using more than one antibiotic to treat the deadly ‘super-bug’, Methicillin-resistant staphylococcus aureus (MRSA) Bacteremia, commonly known as Golden Staph.

Source: Second antibiotic no advantage for treating super-bug Golden Staph

About Post Author

Ralph Turchiano

I have a strong affinity for the sciences which led me to create my sites. My compulsion for the past decade has been reviewing literally every peer-reviewed research article. Which can easily be validated by following my posts. To me, science is where the real news is, as it will mold our destiny beyond that of politics or economics. 😉 Please feel free to e-mail: 161803p314159@gmail.com

vhstore@comcast.net

http://healthresearchreport.wordpress.com

Happy

0 %

Sad

0 %

Excited

0 %

Sleppy

0 %

Angry

0 %

Surprise

0 %

Breaking News

Vitamin D twice a day may keep vertigo away

Turmeric supplement more effective than placebo for osteoarthritis knee pain

COVID-19 pandemic halts cancer care and damages oncologists’ wellbeing

Gut microbes could allow space travelers to stay healthy on long voyages

A pain reliever that alters perceptions of risk

COVID deaths closely match “normal” age-related risk pattern, says expert

Probiotic skin therapy improves eczema in children, NIH study suggests

Vitamin B1 deficiency a key factor in the development of alcohol-related dementia

Substances with anti-cancer action are identified in Brazilian red propolis

Green light therapy shown to reduce migraine frequency, intensity

Second antibiotic no advantage for treating super-bug Golden Staph

About Post Author

Ralph Turchiano

Like this:

Related

Average Rating

Researchers were not right about left brains

Feasibility of using cells from fat tissue to treat scarred vocal cords

Breaking News

Share this:

Like this:

Related

Average Rating

Related Post